Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01644110
Title Ruxolitinib and Pomalidomide Combination Therapy in Patients With Primary and Secondary MF (POMINC)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Ulm
Indications

myelofibrosis

myeloproliferative neoplasm

Therapies

Pomalidomide + Ruxolitinib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.